ALLO 424B5: Secondary offering
Allogene Therapeutics
Filed with the SEC on · accession 0001628280-26-044616
ALLO filed a 424B5 (prospectus (offering)) with the SEC on Jun 22, 2026. The final terms of an offering of shares or bonds. The stock moved +5.0% by the first close after the filing.
Summary of the filing
Allogene Therapeutics entered into a sales agreement with TD Cowen to offer and sell up to $135,000,000 of its common stock in an at-the-market offering.
Key details
How ALLO stock reacted
Close before
$2.00
Jun 18, 2026
First close after
+5.00%
$2.10
5 trading days
+6.50%
$2.13
Since filing
-45.50%
$1.09
✦ Ask GOAX AI about this filing — what it means for ALLO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ALLO?
Click hereFrequently asked questions
What did ALLO file with the SEC on Jun 22, 2026?
ALLO filed a 424B5 (Secondary offering). Allogene Therapeutics entered into a sales agreement with TD Cowen to offer and sell up to $135,000,000 of its common stock in an at-the-market offering.
What does a secondary offering mean for ALLO stock?
New shares dilute existing holders and are often sold at a discount to the market price.
How do I read a 424B5?
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B5 (prospectus (offering)): The final terms of an offering of shares or bonds.
How did ALLO stock react to this filing?
ALLO closed at $2.00 before the filing and $2.10 on Jun 22, 2026 (+5.00%). Five trading days later: $2.13 (+6.50%).
Other ALLO SEC filings
Get alerts when ALLO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days